Form 4: Strata Critical Medical Co-CEO Sells Shares for Tax Obligations

William A. Heyburn, Co-CEO and CFO of Strata Critical Medical, Inc., reported the disposition of 35,348 shares of Class A common stock to satisfy tax withholding obligations.

Summary

• William A. Heyburn, who serves as Co-CEO, CFO, and a Director of Strata Critical Medical, Inc. (SRTA), reported a transaction.
• On December 10, 2025, Mr. Heyburn disposed of 35,348 shares of Class A common stock.
• The disposition was made at a price of $4.38 per share.
• These shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• Following this transaction, Mr. Heyburn beneficially owns 1,368,088 shares of Class A common stock directly.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction for tax purposes related to RSU vesting, which is neither inherently positive nor negative for the company's operational performance or stock value.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Minor impact as it represents a routine tax-related disposition, indicating the vesting of restricted stock units which is part of the executive compensation structure.

Key Dates

Recommendation

This Form 4 filing details a routine disposition of shares by an insider to cover tax obligations related to the vesting of restricted stock units. Such transactions are common and do not typically reflect a change in management's confidence in the company's future or its operational performance. Therefore, it provides no new information that would warrant a change in investment recommendation.

Keywords

Strata Critical Medical, SRTA, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, William A. Heyburn, Co-CEO, CFO, Restricted Stock Units